Spectrum Pharmaceuticals, Inc.
SPPI · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $16 | $10 | $0 | $0 |
| % Growth | 54.4% | – | -100% | – |
| Cost of Goods Sold | $1 | $2 | $0 | $0 |
| Gross Profit | $15 | $8 | -$0 | -$0 |
| % Margin | 93.2% | 82.3% | – | -7.7% |
| R&D Expenses | $5 | $9 | $13 | $16 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $14 | $11 | $8 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $19 | $20 | $22 | $25 |
| Operating Income | -$5 | -$12 | -$22 | -$25 |
| % Margin | -31.2% | -115.1% | – | -65,107.7% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$4 |
| Pre-Tax Income | -$5 | -$12 | -$22 | -$29 |
| Tax Expense | $0 | -$3 | $0 | $0 |
| Net Income | -$5 | -$9 | -$22 | -$29 |
| % Margin | -32.9% | -88.4% | – | -74,474.4% |
| EPS | -0.026 | -0.049 | -0.12 | -0.17 |
| % Growth | 47.7% | 59.3% | 29.4% | – |
| EPS Diluted | -0.026 | -0.049 | -0.12 | -0.17 |
| Weighted Avg Shares Out | 202 | 183 | 188 | 176 |
| Weighted Avg Shares Out Dil | 202 | 183 | 188 | 176 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$4 | -$11 | -$22 | -$29 |
| % Margin | -26% | -107.1% | – | -73,951.3% |